NEW YORK (GenomeWeb News) – Exact Sciences today priced its common stock offering of 10 million shares at $12.75 per share.

The Madison, Wis.-based molecular diagnostics firm expects net proceeds from the offering to be around $119.7 million. However, the underwriters of the offering have a 30-day option to purchase up to an aggregate of 1,500,000 additional shares of common stock.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Kansas City Star examines issues surrounding newborn genome sequencing.

Researchers say their Research Resource Identifier citation format is catching on, Nature News reports.

In Science this week: the Human Silencing Hub protein complex, and more.

Heads of various research funding agencies discuss how to encourage scientific breakthroughs, ScienceInsider reports.